chrisvoncsefalvay/vaers-outcomes huggingface dataset:
having intermittent left-sided chest pain/The pain is worsened with deep breathing.; palpitations; This is a spontaneous report from a contactable Other Healthcare professional (HCP) (patient). A 30-year-old female patient (pregnant: No) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1283), via Intramuscular on left arm on 06Jan2021 at 14:00 at single dose for COVID-19 immunisation. The relevant medical history included known allergies: Penicillin and known allergies: Sulfa. Concomitant medications were reported as none. The patient previously took Ceclor and had known allergies. The day after receiving the first dose, on 07Jan2021 at 15:00 the patient had been having intermittent left sided chest pain. The pain was worsened with deep breathing. Additionally having palpitations. It had caused her enough concern that she went to the ED (Emergency room/department or urgent care). She had been encouraged to follow up in clinic. No other vaccine in four weeks. No other medications in two weeks. No Covid prior vaccination. No covid tested post vaccination. The outcome of the events was not recovered.
3-6-14 1155AM - Dr calls and says patient presents to their clinic complaining of fatigue and ulcers lower lip and tongue for "2-3 days". Doctor requested VIS info, on each vaccine. Says he doesn't think symptoms relate to vaccines, but will do additional testing/blood work and call if he finds any significant info. Says he will also hydrate client - no other information shared.
This spontaneous report was received from a registered pharmacist and refers to a 73 year old patient of unknown gender. Information regarding pertinent medical history, drug reactions or allergies and concomitant therapy was not reported. On 10-JUL-2017, the patient was vaccinated with an improperly stored ZOSTAVAX, lot number M041087 with expiration date 03-JAN-2018 (dosage schedule, anatomical location and route of administration not provided) for prophylaxis, reconstituted with properly stored diluent (MRK INJ). The administered vaccine was exposed to a temperature of 6 degree Fahrenheit to 14 degree Fahrenheit for 1 hour. Previous temperature excursion was reported as 6 degree Fahrenheit to 14 degree Fahrenheit for 45 minutes. The call was because of a data logger. No adverse effects were reported. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1708USA010696: US-009507513-1708USA010732: US-009507513-1709USA014569: US-009507513-1709USA014570: US-009507513-1709USA014572: US-009507513-1709USA014573: US-009507513-1709USA014574: US-009507513-1709USA014575: US-009507513-1709USA014576: US-009507513-1709USA014577.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age. On 03-MAY-2013 the patient was given an expired dose of MMR II (lot number 0515AA; expired date 08-APR-2013) (dose, route, frequency, indication and injection site were not reported). No adverse effect reported. The outcome was unknown. The action taken and causality were not provided. It was unspecified if the patient sought any medical attention. Additional information has been requested.
burning itchy red bumpy rash started on left elbow, then spread to right elbow.  Went to dermatologist on 2/24 for biopsy (gluten rash, psoriasis) and was prescribed  Clobetasol  2x day. Rash dried up with skin flaking and peeling in about 5 days.  Second vaccine received 3/4, no rash as of 3/10
This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (bad taste after the first dose), ASTHENIA (wave of weakness), DIZZINESS (lightheaded), PARAESTHESIA ORAL (tingling in the tongue) and RASH (rash on the feet) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A and 015M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Feb-2021, the patient experienced DYSGEUSIA (bad taste after the first dose). On 02-Mar-2021, the patient experienced ASTHENIA (wave of weakness), DIZZINESS (lightheaded) and PARAESTHESIA ORAL (tingling in the tongue). On an unknown date, the patient experienced RASH (rash on the feet). The patient was treated with PREDNISONE at an unspecified dose and frequency. On 02-Feb-2021, DYSGEUSIA (bad taste after the first dose) had resolved. On 02-Mar-2021, ASTHENIA (wave of weakness), DIZZINESS (lightheaded) and PARAESTHESIA ORAL (tingling in the tongue) had resolved. At the time of the report, RASH (rash on the feet) outcome was unknown. Not Provided          Patient was taking antihistamine per doctor recommendation. No concomitant medication details was reported.
This case was reported by a other health professional via call center representative and described the occurrence of hearing loss in a female patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX .5 ml. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced hearing loss (serious criteria GSK medically significant). On an unknown date, the outcome of the hearing loss was unknown. It was unknown if the reporter considered the hearing loss to be related to SHINGRIX. Additional details were provided as follows: This case was reported by a medical assistant. The age at vaccination was not reported. The reporter had limited information and would call back to provide additional details. There was no other details were available at the time of reporting.
Pt arm got swollen pain and itchy. It also developed red welts. Pt took some BENADRYL last night.
This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of BONE PAIN (Bones ached), DIZZINESS (Dizzy/bad balance), DYSPNOEA (Getting out-of-breath easily), MYALGIA (Body aches) and FATIGUE (Barely could get out of bed; Fatigue) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (experienced some lingering symptoms from that) in January 2021.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PYREXIA (High fever). On 04-Feb-2021, the patient experienced BONE PAIN (Bones ached), DIZZINESS (Dizzy/bad balance), MYALGIA (Body aches), FATIGUE (Barely could get out of bed; Fatigue), HEADACHE (Felt like her head was exploding) and CHILLS (Chills). On 05-Feb-2021, the patient experienced DYSPNOEA (Getting out-of-breath easily). The patient was treated with NAPROXEN (MOTRIN [NAPROXEN]) for Fever, at a dose of UNK dosage form. On 06-Feb-2021, DIZZINESS (Dizzy/bad balance), MYALGIA (Body aches), HEADACHE (Felt like her head was exploding) and CHILLS (Chills) had resolved. At the time of the report, BONE PAIN (Bones ached) and FATIGUE (Barely could get out of bed; Fatigue) had not resolved, DYSPNOEA (Getting out-of-breath easily) outcome was unknown and PYREXIA (High fever) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Feb-2021, Body temperature: 102 (High) 102 degrees F. On , Body temperature: high High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported.
Information has been received from a registered nurse concerning an 86 year old male with no medical history or allergies who on 17-APR-2006 at 1315 was vaccinated subsequently with a first dose of Pneumovax 23 (lot #651332/1049P). There was no illness at the time of vaccination. On 18-APR-2006 at 1500 the injection site was red, warm to the touch and swollen. It was noted
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 2010, the patient was vaccinated with a dose of ZOSTAVAX (lot #, expiration date, dose, route and site of administration were not reported) to obtain permanent prevention and protection against shingles and zoster-related injuries. On an unknown date, after and despite being inoculated with the ZOSTAVAX, the patient was diagnosed with shingles and/or other zoster-related injuries and suffered serious physical, emotional and economic damages as a result of patient's injuries. On or about 2013, the patient was treated for shingles. The reporter considered adverse events to be related to ZOSTAVAX. As a direct and proximate result of the ZOSTAVAX, the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care - for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. By the time of the report, the patient did not recover from shingles as the patient suffer for ongoing injuries. The outcome of vaccination failure was unknown. The events were considered to be related to ZOSTAVAX.
1st  COVID 19 injection 3/5/21...mild sore arm at injection site on day 2 and 3 pain level 1.  2nd COVID 19 injection 4/5/21. Sore arm at injection site on day 1 pain level 1, day 2-3  pain level 3, day 4 pain level 1;  Tired days 1-6,  Slight headache days 1, 3, 4 no need for medication Severe migraine day 2...woke up with 1 dose Cambia headache mostly resolved and then came back about 6 hours later requiring 2nd dose of Cambia,  Chills/fever day 2 highest temp 101.4 from 2:00 pm to 8:00 pm 2nd dose of Cambia broke fever.
Unusual slight nose bleed; tired; chills; minor injection site pain; This is a spontaneous report from a contactable consumer, the patient. A 75-years-old male patient received his first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration in the right arm on 19Mar2021 at 09:00 (at the age of 75-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 19Mar2021 at 19:00 the patient experienced an unusual slight nose bleed in the night after, the patient experienced tired, chills and minor injection site pain. The patient received tylenol (MANUFACTURER UNKNOWN) for the treatment of events. It was reported that adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events unusual slight nose bleed, tired, chills and vaccination site pain were recovered on an unknown date.   Information about the lot number cannot be obtained. No further information is expected.
Dizzy, fainting feeling sweating. PO TYLENOL 650mg, BENADRYL 25mg PO and fluids also Hx of Diabetes Sugar fluids given for possible decrease BS.
She did a home COVID-19 test twice on 09AUG2023, and both times it came back positive; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (She did a home COVID-19 test twice on 09AUG2023, and both times it came back positive) in a 67-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 049D22A) for COVID-19 prophylaxis.     The patient's past medical history included Surgery. Concurrent medical conditions included Mite allergy and Immune system disorder.    On 17-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 09-Aug-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced COVID-19 (She did a home COVID-19 test twice on 09AUG2023, and both times it came back positive). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19, at an unspecified dose and frequency. At the time of the report, COVID-19 (She did a home COVID-19 test twice on 09AUG2023, and both times it came back positive) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Aug-2023, SARS-CoV-2 test: Positive and Positive.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not reported. Patient received first primary monovalent dose on 29-Jun-2021 (Lot number: 0051C21A & Exp. Date: unknown) and 2nd primary monovalent dose on 28-Jul-2021 (Lot number: 040C21A & Exp. Date: unknown) of Moderna.  Patient had symptoms of muscle aches and pain, arms were hurting, then got extremely sick on 09-Aug-2023. Patient did home Covid-19 test twice and was positive. Patient was treated with Paxlovid.   This case was linked to US-MODERNATX, INC.-MOD-2023-738502 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 25-Aug-2023: Non-significant follow up received.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-738502:Wife case (Monovalent product)
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 012L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced VACCINATION SITE PAIN (Sore arm). At the time of the report, VACCINATION SITE PAIN (Sore arm) outcome was unknown.            No concomitant product use was provided by the reporter. No treatment medication was provided. The patient was not immunocompromised.   This case was linked to MOD-2021-363393, MOD-2021-363338 (Patient Link).
Mbr developed dizziness about an hour after receiving vaccination and was evaluated..  Vital signs and physical exam were all unremarkable.  Negative for any other sxs.  Negative for any neurological abnormalities on exam.  No cognitive deficits.   She was sent home to rest and hydrate with ED precautions.
At time of injection there was no abnormal pain or reaction.  Injection was received in the left deltoid.  An hour after receiving the injection, the deltoid became very hard and contracted.  It was painful, 7/10 on a pain scale.  Hardness and contraction continued for about 7 hours.  A headache started 2 hours after receiving the injection.  Today, 10-08-2010 the deltoid is very tender and noted redness on skin.  The entire left arm is weaker than usual. Body feels weaker.
A two year old pt with no preexisting medical history or illness, had received a first injection of Fluzone sv 2005-2006 usp, lot number U41753AA on 10Oct05. The route/site of admin were not reported. Two days later the pt developed generalized urticaria throughout the entire body. The pt was seen by a physician and was treated with a antihistamine and a steroid. His/her condition is improving but still persists at the time of this report.
After the vaccination on 2/10/21, I felt dizzy/off EVERY morning, badly enough that I did not drive in the AM.  When I took my Crestor dose at breakfast, I felt a additional rush.  After walking/moving around for awhile, I felt better for the rest of the day. On 3/3/21 after 3 weeks, I contacted my doctor about these symptoms.  She had me do the Epley maneuver for dizziness at home and then in her office on 3/5/21.  She noted a slight drop in blood pressure with standing. She arranged a panel of blood tests and an ECG 12 lead.  She told me that I should watch my symptoms and wait.  Call if anything new developed.  After about 2 more weeks of feeling dizzy/off in the mornings, (5 weeks total), I felt okay again. Test results: 3/5/21 ECG Impression BORDERLINE ECG -Sinus rhythm, Nonspcific ST abnormalities, Blood tests: Glucose slightly elevated at 106 mg/dL, TSH slightly elevated at 4.24 ulU/mL, borderline Hemoglobin A1c 5.9% with mean glucose 123 mg/dL.
Patient had Covid vaccine yesterday morning. Developed fever and vomiting at 9pm last night. Brought to the ER poorly responsive. Found to have a large intracranial bleed with an apparent ruptured AVM. Sent to larger hospital for pediatric neurointerventional radiology and pediatric neurosurgical care.
Pt recv vax on 9/23/97; on 9/30/97 pt exp enlarged spleen (3 cm), low iron;  1 month later pt exp dental abscess post "minor caries repair".
Pt. rec'd High Dose FLUZONE on Sunday 9/18/2016. Called Wed. 9/21/16 in AM to report swelling, redness, head at inj. site and soreness. Tried with ice previous night. Saw doctor today which said to ice area. (MD at Center) looks like a locally reaction.
Very hot, swollen, feels hard, itchy. Try Motrin and Benadryl.
Day after injection felt a bit achy and low energy and took Tylenol. Lasted all day but symptoms weren?t severe. The following day had a red patch under injection site and warm to the touch. No treatment yet, will observe to see if it gets bigger.
Red and warm from groin to knee, L thigh. Brick hard, pain to bear weight, fever x1 day. At sight of immunization, white dime-sized area with small red spot in center.
CLIENT BECAME NAUSEATED AFTER VACCINATION AND COMPLAINED OF BEING DIZZY. SHE WAS INSTRUCTED TO REMAIN SEATED 15 MIN. BP WAS CHECKED 3 TIMES. TWICE SITTING, 1 STANDING. SENT HOME WITH MOM AFTER STATING "I FEEL BETTER'.
I have been experiencing a heavy period flow with severe clotting for 39 days. The day after my first vaccination I started my period, normal at first, a bit heavy, though it continued and continued without stopping. I never connected it to my vaccination however its clear that it is the cause of my heavy menstrual flow.
Dizziness Narrative: Employee states she had dizziness since after she had vaccine-it just reporting this now in Sept
Tachycardia heart rate 135 bpm at rest; shortness of breath oxygen saturation 90%; Chest tightness; burning; This is a spontaneous report from a contactable other hcp/nurse (patient). A 41-years-old non pregnant female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot Number: EK9231 and expiry date: unknown), dose 1 via intramuscular, administered in Arm Right on 13Jan2021 14:30 as SINGLE DOSE for covid-19 immunisation. Medical history included female pattern hair loss. The patient previously took clindamycin and experienced drug hypersensitivity, compazine [prochlorperazine edisylate] and experienced drug hypersensitivity. Prior to vaccination, the patient was diagnosed with COVID-19. Patient not tested covid post vaccination. No other vaccines were received within 4 weeks prior to the COVID vaccine. Concomitant medications included fluticasone furoate, vilanterol trifenatate (BREO ELLIPTA), montelukast sodium (SINGULAIR), vitamin d3 (VITAMIN D3), folic acid (VITAMIN B12 & FOLIC ACID) and finasteride (FINASTERIDE). The patient experienced tachycardia heart rate 135 bpm at rest, shortness of breath oxygen saturation 90%, Chest tightness and burning on 13Jan2021 23:45. The patient underwent lab tests and procedures which included heart rate: 135 bpm at rest on an unknown date, oxygen saturation: 90 % on an unknown date. No treatment received for the events. Outcome of all the events was recovered with lasting effects.  Follow-up (14May2021): Follow-up attempts completed. No further information expected.
This spontaneous report as received from a nurse refers to a 10 months 22 days old female patient. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) ROTATEQ lot # K016313, exp. date: 31-MAY-2016 and lot # K01166, exp. date: 20-MAY-2016 (dose and strength unspecified) oral. No concomitant medications were reported. No adverse experiences have been reported so far. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were provided.
Patient and guardian were both with dialect different. Patient was asked to verify DOB, she reported another DOB with a document to support it. Then upon checking out after receiving vaccines, the guardian presented another document that reported a different DOB, which was finally confirmed the actual correct DOB. Patient was given extra dose of MMR and Polio vaccine not needed for her correct age and immunization record. No adverse effects from the vaccines given.
I was shaky and weak, just felt really bad, like I wasn't functioning. I stayed most of the day in bed and I gradually started to feel better.
Redness & swelling (6 cm x 4 cm) at injection site and 4 days of fever, sweats, chills, myalgias.
Mild Allergic Reaction- Doctor prescribed EpinePhrine 0.3 mg injection just in case for the 2nd dose
I came home and started setting the table for lunch around 1:00PM and got a headache that worsened during the night. I had fever, chills, and body aches, that went away but the headache and some dizziness did not. I went to the Urgent Care, but they didn't know what was wrong. I was referred to a neurologist for a CT scan that didn't show anything but I still had the headaches. I later took some Benadryl that finally helped. My headaches lasted about a month and I just recovered about two weeks ago.